| Size | Price | Stock |
|---|---|---|
| 1g | $25 | In-stock |
| 5g | $58 | In-stock |
| 10g | $80 | In-stock |
| 50 g | Get quote | |
| 100 g | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-B1883 |
| M.Wt: | 256.13 |
| Formula: | C12H11Cl2NO |
| Purity: | >98 % |
| Solubility: | DMSO : 200 mg/mL (ultrasonic) |
Propyzamide (Kerb) is an orally active inhibitor of β-tubulin and AHR signaling pathways. Propyzamide binds β-tubulin at the intradimer interface, disrupting microtubule assembly, leading to mitotic arrest and multipolar spindle formation. Propyzamide enhances C/EBPβ and NF-κB signaling, promoting colitogenic helper T cell differentiation and interleukin-17/interferon gamma-expressing colonic T cells. Propyzamide can be used in research on colitis, inflammatory bowel disease, and liver cancer[1][2][3][4][5][6].
In Vitro:Propyzamide (2-10 µM) boosts Th1/Th17 differentiation in mouse naive CD4+ T cells and human CD3+ T cells in an NF-κB-C/EBPβ-dependent manner[2].
Propyzamide (20 μM; 48-72 h) arrests Vigna radiata root meristem cells in prophase (83.41% at 48 h; 73.26% at 72 h) and disrupts spindle microtubules[5].
Propyzamide (100 μM; 6 days) inhibits Nicotiana tabacum cv. BY-2 cell division, reaching 53% inhibition in the conductivity assay[6].
Propyzamide (0.75 μM-0.1 M; 24 h) causes complete depolymerization of cortical and spindle microtubules and induces multipolar spindle formation in Nicotiana tabacum cv. BY-2 cells[6].
Propyzamide (2-10 µM) suppresses FICZ-induced AHR-target gene expression in human and mouse primary DCs and T cells[2].
Propyzamide (2-10 µM) enhances T cell activation and Th1/Th17 polarization in mouse and human DCs, dependent on C/EBPβ[2].
Propyzamide (2 µM) promotes C/EBPβ recruitment to Ifng, Il12rb1, and Rorc promoters in mouse T cells[2].
Propyzamide (2-10 µM) boosts NF-κB activation and pro-inflammatory cytokine expression in mouse and human DCs[2].
Propyzamide (50 μM; 24 h) activates xenobiotic metabolism and nuclear receptor signaling pathways in differentiated HepaRG cells, with predicted PXR, CAR, NRF2, and PP2A subunit induction[3].
Propyzamide (3.13-50 μM; 24 h) induces CYP2B6 and CYP3A4 expression in differentiated HepaRG cells from 6.25 μM, with 3.4- and 3.0-fold increases at 50 μM[3].
Propyzamide (3.13-50 μM; 24 h)-induced CYP1A2, CYP2B6, and CYP3A4 expression in differentiated HepaRG cells is suppressed by MC-LA or MC-LR at 0.6 μM, demonstrating functional antagonism[3].
Propyzamide (50 μM; 24 h) combined with MC-LR (0.6 μM) produces transcriptional profiles in differentiated HepaRG cells that largely resemble MC-LR alone while adding HCC- and inflammation-related DEGs[3].
Propyzamide (300-1,000 µM; overnight at 4 °C) competes with [3H]TCDD for binding to mouse and human AHR in cell-free assays[2].
Propyzamide (10 µM) inhibits FICZ-induced AHR activation in HEK293FT/DC2.4 AHR reporter cells[2].
Propyzamide (10 µM) activates VCAM1 and C/EBPβ-dependent pro-inflammatory promoters in reporter assays[2].
Propyzamide (3.13-50 μM; 24 h) alone is not cytotoxic in differentiated HepaRG cells up to 50 μM, whereas combined with 0.6 μM MCs it reduces viability to approximately 80% at 50 μM[3].
Propyzamide (50 μM; 24 h) weakly inhibits PP2A activity in differentiated HepaRG cells, with a relative activity of 0.84[3].
Propyzamide (50 µM; 48 h) disrupts β-tubulin immunolocalization in C. vulgaris spermatids, reducing signals at stages IV-VI and eliminating them from stages VII-X, with nuclear distortion at stages V, VII, and VIII[4].
Propyzamide (50 µM; 48 h) induces extensive ultrastructural abnormalities in C. vulgaris spermatids, including nuclear envelope invagination/fragmentation, disturbed chromatin condensation, dilated ER and autolytic vacuoles, and fragmented microtubular manchette, while flagella remain largely correctly formed[4].
Propyzamide (20 μM; 24-72 h) inhibits Vigna radiata seedling root elongation by approximately 20-25%[5].
Propyzamide (20 μM; 24-72 h) impairs lateral root development and causes root tip thickening in Vigna radiata seedlings[5].
In Vivo:Propyzamide (100 mg kg−1; gavage; 7 days) worsens anti-CD3-induced enteritis and T cell-driven small intestinal inflammation in mice[2].
Propyzamide (100 mg kg−1; intraperitoneally for 3 days and/or oral gavage) does not initiate intestinal inflammation or alter baseline intestinal immune populations in healthy mice[2].
Propyzamide (100 mg kg−1; intraperitoneally for 3 days until TNBS presensitization; then oral gavage for 6 consecutive days until TNBS rectal challenge) worsens TNBS-induced colitis in mice by amplifying pro-inflammatory AHR-NF-κB-C/EBPβ signalling[2].
Propyzamide (0.2-20 μM; in E3 medium; 24-72 h) amplifies TNBS-induced intestinal inflammation in zebrafish without initiating inflammation in naive larvae[2].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.